ID: ALA3277922

Max Phase: Preclinical

Molecular Formula: C22H21Br2ClN4O2

Molecular Weight: 532.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)c1ccc(OCc2ccc(COc3ccc(C(=N)N)cc3Br)cc2)c(Br)c1

Standard InChI:  InChI=1S/C22H20Br2N4O2.ClH/c23-17-9-15(21(25)26)5-7-19(17)29-11-13-1-2-14(4-3-13)12-30-20-8-6-16(22(27)28)10-18(20)24;/h1-10H,11-12H2,(H3,25,26)(H3,27,28);1H

Standard InChI Key:  SAIITVIVBYYQJK-UHFFFAOYSA-N

Associated Targets(Human)

Plasma 7708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thrombin 1630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glandular kallikrein 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 532.24Molecular Weight (Monoisotopic): 529.9953AlogP: 4.94#Rotatable Bonds: 8
Polar Surface Area: 118.20Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 11.80CX LogP: 4.49CX LogD: -0.33
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.24Np Likeness Score: -0.28

References

1. Geratz JD, Cheng MC, Tidwell RR..  (1976)  Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.,  19  (5): [PMID:1271404] [10.1021/jm00227a011]

Source